Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Change in Account Payables (2022 - 2025)

Corvus Pharmaceuticals has reported Change in Account Payables over the past 4 years, most recently at $517000.0 for Q4 2025.

  • Quarterly results put Change in Account Payables at $517000.0 for Q4 2025, down 27.08% from a year ago — trailing twelve months through Dec 2025 was -$91000.0 (down 108.61% YoY), and the annual figure for FY2025 was -$91000.0, down 108.61%.
  • Change in Account Payables for Q4 2025 was $517000.0 at Corvus Pharmaceuticals, up from -$1.2 million in the prior quarter.
  • Over the last five years, Change in Account Payables for CRVS hit a ceiling of $1.8 million in Q2 2025 and a floor of -$2.3 million in Q4 2022.
  • Median Change in Account Payables over the past 4 years was $165500.0 (2022), compared with a mean of $57875.0.
  • Peak annual rise in Change in Account Payables hit 561.87% in 2025, while the deepest fall reached 1616.67% in 2025.
  • Corvus Pharmaceuticals' Change in Account Payables stood at -$2.3 million in 2022, then skyrocketed by 105.38% to $121000.0 in 2023, then soared by 485.95% to $709000.0 in 2024, then fell by 27.08% to $517000.0 in 2025.
  • The last three reported values for Change in Account Payables were $517000.0 (Q4 2025), -$1.2 million (Q3 2025), and $1.8 million (Q2 2025) per Business Quant data.